Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer
ENPE-CRF
Effect of Evidence-Based Nursing Combined With Progressive Gymnastics Training on Cancer-Related Fatigue, Quality of Life, and Treatment Adherence in Patients With Advanced Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to evaluate the effectiveness and safety of evidence-based nursing combined with progressive exercise training in patients with advanced lung cancer undergoing chemotherapy. Cancer-related fatigue (CRF) is a common and distressing symptom in this population and is associated with poor quality of life and reduced treatment adherence. In this single-center, prospective randomized controlled trial, 100 patients with stage III-IV lung cancer receiving platinum-based chemotherapy were randomly assigned to either a control group or an intervention group. The control group received routine nursing care, while the intervention group received evidence-based nursing combined with a structured progressive exercise program for 8 weeks. The primary outcomes are cancer-related fatigue assessed by the Brief Fatigue Inventory (BFI) and functional exercise capacity assessed by the 6-minute walk test (6MWT). Secondary outcomes include quality of life (EORTC QLQ-C30), treatment adherence (MMAS-8), psychological status (HADS), sleep quality (PSQI), and safety outcomes. The study is designed to determine whether a combined intervention approach integrating nursing care and exercise rehabilitation can provide greater benefits than routine care alone in improving both physical and psychological outcomes in patients with advanced lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedFirst Submitted
Initial submission to the registry
March 18, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedMarch 27, 2026
March 1, 2026
1.5 years
March 18, 2026
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Cancer-Related Fatigue Assessed by the Brief Fatigue Inventory (BFI)
Cancer-related fatigue is assessed using the Brief Fatigue Inventory (BFI), a validated scale ranging from 0 to 10, with higher scores indicating more severe fatigue. The outcome measure is the change in total BFI score.
Baseline; Week 8
Change in Functional Exercise Capacity Assessed by the 6-Minute Walk Test (6MWT)
Functional exercise capacity is assessed using the 6-minute walk test (6MWT), which measures the distance a participant can walk in 6 minutes. The outcome measure is the change in walking distance (meters).
Baseline; Week 8
Secondary Outcomes (5)
Change in Quality of Life Assessed by the EORTC QLQ-C30
Baseline; Week 8
Change in Treatment Adherence Assessed by the Morisky Medication Adherence Scale (MMAS-8)
Baseline; Week 8
Change in Psychological Status Assessed by the Hospital Anxiety and Depression Scale (HADS)
Baseline; Week 8
Change in Sleep Quality Assessed by the Pittsburgh Sleep Quality Index (PSQI)
Baseline; Week 8
Incidence of Adverse Events
Baseline through Week 8
Study Arms (2)
Intervention Group: Evidence-Based Nursing Plus Progressive Exercise
EXPERIMENTALParticipants in the intervention group received routine nursing care combined with evidence-based nursing and a structured progressive exercise training program for 8 weeks. Evidence-based nursing included individualized health education, psychological support, symptom management, and family involvement based on current best evidence. The exercise program consisted of aerobic and resistance training with gradually increasing intensity, tailored to each patient's physical condition and tolerance, and supervised by rehabilitation specialists and nursing staff.
Control Group: Routine Nursing Care
ACTIVE COMPARATORParticipants in the control group received routine nursing care, including standard health education, dietary guidance, symptom monitoring, and general psychological support. No structured exercise rehabilitation program or evidence-based nursing protocol was provided.
Interventions
Evidence-based nursing included individualized health education, psychological support, symptom management, and family involvement strategies based on current best available evidence. Nursing interventions were tailored to patients' clinical conditions and aimed to improve symptom control, treatment adherence, and overall quality of life.
Progressive exercise training consisted of aerobic and resistance exercises with gradually increasing intensity over an 8-week period. The program was individualized based on patients' physical condition and tolerance, and included activities such as walking, Tai Chi, and light resistance training. Exercise sessions were supervised by rehabilitation specialists and nursing staff.
Routine nursing care included standard health education, dietary guidance, symptom monitoring, and general psychological support provided during chemotherapy, without a structured evidence-based nursing protocol or exercise program.
Eligibility Criteria
You may qualify if:
- Pathologically confirmed advanced lung cancer (stage III-IV)
- Currently receiving platinum-based chemotherapy (first to fourth cycle)
- Age ≥18 years
- Karnofsky Performance Status (KPS) score ≥60
- Presence of moderate or more severe cancer-related fatigue, defined as a Brief Fatigue Inventory (BFI) score ≥4
- Expected survival time of more than 6 months
- Ability to understand the study procedures and provide written informed consent
You may not qualify if:
- Severe cardiopulmonary insufficiency or other conditions that contraindicate exercise intervention
- Cognitive impairment or mental disorders affecting compliance with the intervention
- Musculoskeletal disorders that limit physical activity or exercise participation
- Presence of other advanced malignant tumors
- Rapid disease progression during the study period requiring discontinuation of the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanxi Province Cancer Hospital
Taiyuan, Shanxi, 030013, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qingjuan Li, MD
Shanxi Province Cancer Hospital, Taiyuan, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, participants and care providers were not blinded. Outcome assessors and data analysts were blinded to group allocation to reduce assessment and analysis bias.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2026
First Posted
March 27, 2026
Study Start
January 1, 2023
Primary Completion
June 30, 2024
Study Completion
August 30, 2024
Last Updated
March 27, 2026
Record last verified: 2026-03